Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xilu Wang

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
JBMR Plus|August 6, 2025
Surgical periosteal resection changes bone geometry and strength in New Zealand white rabbitsMatthew A Halanski, Rajeev Chaudhary, Grant Ozaki, et al.
Muscle & Nerve|April 1, 2024
Pseudoexon activation by deep intronic variation in GNE myopathy with thrombocytopeniaKexin Jiao, Nachuan Cheng, Xiao Huan, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Structure-Based Design of A-1293102, a Potent and Selective BCL-X<sub>L</sub> InhibitorZhi-Fu Tao, Xilu Wang, Jun Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2010
Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMRAndrew M Petros, Jeffrey R Huth, Thorsten Oost, et al.
The Lancet. Child & Adolescent Health|February 21, 2023
Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trialLidong Gao, Yan Li, Peng He, et al.
Journal of Medicinal Chemistry|October 10, 2008
Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteinsCheol-Min Park, Milan Bruncko, Jessica Adickes, et al.
Brain : a Journal of Neurology|December 29, 2020
5' UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathyJianying Xi, Xilu Wang, Dongyue Yue, et al.
Journal of Medicinal Chemistry|January 20, 2006
Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesisAndrew M Petros, Jurgen Dinges, David J Augeri, et al.
Journal of Medicinal Chemistry|January 23, 2004
Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitorsLe Wang, Gary T Wang, Xilu Wang, et al.
Journal of Medicinal Chemistry|January 30, 2007
Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xLMilan Bruncko, Thorsten K Oost, Barbara A Belli, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
JBMR Plus|August 6, 2025
Surgical periosteal resection changes bone geometry and strength in New Zealand white rabbitsMatthew A Halanski, Rajeev Chaudhary, Grant Ozaki, et al.
Muscle & Nerve|April 1, 2024
Pseudoexon activation by deep intronic variation in GNE myopathy with thrombocytopeniaKexin Jiao, Nachuan Cheng, Xiao Huan, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Structure-Based Design of A-1293102, a Potent and Selective BCL-X<sub>L</sub> InhibitorZhi-Fu Tao, Xilu Wang, Jun Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2010
Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMRAndrew M Petros, Jeffrey R Huth, Thorsten Oost, et al.
The Lancet. Child & Adolescent Health|February 21, 2023
Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trialLidong Gao, Yan Li, Peng He, et al.
Journal of Medicinal Chemistry|October 10, 2008
Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteinsCheol-Min Park, Milan Bruncko, Jessica Adickes, et al.
Brain : a Journal of Neurology|December 29, 2020
5' UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathyJianying Xi, Xilu Wang, Dongyue Yue, et al.
Journal of Medicinal Chemistry|January 20, 2006
Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesisAndrew M Petros, Jurgen Dinges, David J Augeri, et al.
Journal of Medicinal Chemistry|January 23, 2004
Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitorsLe Wang, Gary T Wang, Xilu Wang, et al.
Journal of Medicinal Chemistry|January 30, 2007
Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xLMilan Bruncko, Thorsten K Oost, Barbara A Belli, et al.
Pageof 4